SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-028008
Filing Date
2023-06-14
Accepted
2023-06-14 17:01:45
Documents
12
Period of Report
2023-06-13
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K hcwb-20230613.htm   iXBRL 8-K 66528
  Complete submission text file 0000950170-23-028008.txt   187631

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT hcwb-20230613_lab.xml EX-101.LAB 14018
3 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT hcwb-20230613_pre.xml EX-101.PRE 10287
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT hcwb-20230613.xsd EX-101.SCH 2469
6 EXTRACTED XBRL INSTANCE DOCUMENT hcwb-20230613_htm.xml XML 4929
Mailing Address 2929 N COMMERCE PKWY MIRAMAR FL 33025
Business Address 2929 N COMMERCE PKWY MIRAMAR FL 33025 954-842-2024
HCW Biologics Inc. (Filer) CIK: 0001828673 (see all company filings)

IRS No.: 825024477 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40591 | Film No.: 231014874
SIC: 2834 Pharmaceutical Preparations